Combination Drug Strategies for Targeting Specific Biochemical Pathways for Superior Therapeutic Potency-Reference-Cited by-同舟云学术

Combination Drug Strategies for Targeting Specific Biochemical Pathways for Superior Therapeutic Potency

Published:2024 Issue: Volume: Page:203-218
ISSN:
Container-title:Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates
language:en
Short-container-title:

Author:

Arjmand Farukh,Tabassum Sartaj,Khan Huzaifa Yasir

Publisher

Springer Nature Singapore

Link

https://link.springer.com/content/pdf/10.1007/978-981-97-0146-9_8

Reference73 articles.

1. Almi I, Belaidi S, Zerroug E, Alloui M, Ben Said R, Linguerri R, Hochlaf M (2020) QSAR investigations and structure-based virtual screening on a series of nitro 18 journal of chemistry Benzoxadiazole derivatives targeting human glutathione-S-transferases. J Mol Struct 1211:128015–128025. https://doi.org/10.1016/j.molstruc.2020.128015

2. Ansfield FJ, Ramirez G, Korbitz BC, Davis HL (1971) Five-drug therapy for advanced breast cancer: a phase I study 12. Cancer Chemother Rep 55:183–187

3. Babak MV, Plażuk D, Meier SM, Arabshahi HJ, Reynisson J, Rychlik B, Błauż A, Szulc K, Hanif M, Strobl S, Roller A, Keppler BK, Hartinger CG (2015) Half-Sandwich ruthenium(II) biotin conjugates as biological vectors to cancer cells. Chem Euro J 21:5110–5117. https://doi.org/10.1002/chem.201403974

4. Bravo-Gómez ME, García-Ramos JC, Gracia-Mora I, Ruiz-Azuara L (2009) Antiproliferative activity and QSAR study of copper(II) mixed chelate [cu(NN) (Acetylacetonato)]NO3 and [cu(N-N) (Glycinato)] NO 3, (Casiopeínas ®). J Inorg Biochem 103:299–309. https://doi.org/10.1016/j.jinorgbio.2008.10.006

5. Brodyagin N, Katkevics M, Kotikam V, Ryan CA, Rozners E (2021) Chemical approaches to discover the full potential of peptide nucleic acids in biomedical applications. Beilstein J Org Chem 17:1641–1688. https://doi.org/10.3762/bjoc.17.116